| Cash Flow | 2026-04-03 | 2026-01-02 | 2025-10-03 | 2025-07-04 |
|---|---|---|---|---|
| Gain on purchase of business | NaN | NaN | 0 | 0 |
| Net (loss) income | -8,000 | 2,400 | 12,200 | -82,100 |
| Impairment of goodwill | NaN | NaN | 0 | 93,900 |
| Share-based compensation expense | 4,000 | 3,800 | 3,400 | 11,600 |
| Depreciation | 5,700 | 5,700 | 5,600 | 17,600 |
| Amortization of intangible assets | 1,100 | 1,100 | 1,100 | 2,900 |
| Deferred taxes | -100 | 600 | 2,700 | -3,200 |
| Loss from equity method investments | -1,300 | -3,200 | -200 | -2,500 |
| Impairment of equity method investment | NaN | NaN | 0 | NaN |
| Amortization of deferred loan costs | -300 | -500 | -400 | -2,300 |
| Inventory write-down | 1,600 | 1,100 | 800 | 3,000 |
| Loss on debt extinguishment | -9,400 | NaN | NaN | NaN |
| Other, net | -1,600 | -500 | 2,000 | -200 |
| Accounts receivable | 1,100 | -8,900 | 20,100 | -20,200 |
| Inventories, net | 21,800 | 30,100 | 2,300 | 37,600 |
| Prepaid expenses and other assets | 7,400 | 2,100 | -1,700 | 5,300 |
| Accounts payable | 16,200 | 12,100 | -5,400 | 11,600 |
| Accrued liabilities and other current and long-term liabilities | -6,400 | -23,800 | 11,500 | -11,400 |
| Deferred revenues | 2,100 | 0 | -1,900 | 7,600 |
| Net cash (used in) provided by operating activities | -1,500 | -16,100 | 7,900 | 33,800 |
| Purchases of property, plant, and equipment | 6,200 | 10,700 | 5,600 | 17,300 |
| Loss on settlement of cash flow hedge | NaN | NaN | 0 | NaN |
| Purchase of marketable equity securities | NaN | NaN | 0 | 0 |
| Settlement of net investment hedge | NaN | NaN | 0 | 800 |
| Proceeds from sales of marketable debt securities | 0 | 0 | 1,000 | 10,500 |
| Acquisitions of businesses, net of cash acquired | NaN | NaN | 0 | 0 |
| Proceeds from maturities of marketable debt securities | 3,100 | 4,000 | 5,200 | 45,300 |
| Purchase of certificates of deposit | NaN | NaN | 0 | NaN |
| Purchase of marketable debt securities | 0 | 0 | 0 | 30,600 |
| Proceeds from maturities of certificates of deposit | 0 | 0 | 0 | 3,400 |
| Other, net | 0 | 1,000 | 1,300 | -500 |
| Net cash (used in) provided by investing activities | -3,100 | -7,700 | -700 | 11,000 |
| Proceeds from issuance of term loans | 345,500 | NaN | NaN | NaN |
| Taxes related to net share settlement of equity awards | 0 | 1,500 | 0 | 1,900 |
| Proceeds from issuance of senior secured notes | 0 | 0 | 0 | 126,900 |
| Debt extinguishment costs | 7,200 | NaN | NaN | NaN |
| Repayments of borrowings | 373,100 | 0 | 400 | 201,500 |
| Proceeds from revolver borrowings | 7,000 | NaN | NaN | NaN |
| Proceeds from exercise of stock options | NaN | NaN | 0 | NaN |
| Repayments of revolver borrowings | 2,600 | NaN | NaN | NaN |
| Payment of debt issuance costs | 0 | NaN | 0 | 1,200 |
| Proceeds from shares issued under employee stock purchase plan | 1,700 | NaN | 1,600 | 1,700 |
| Other, net | -600 | -100 | -100 | -1,000 |
| Net cash (used in) provided by financing activities | -29,300 | -1,600 | 1,100 | -77,000 |
| Effects of exchange rate changes on cash and cash equivalents and restricted cash | -100 | NaN | 300 | 300 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | -34,000 | -25,400 | 8,600 | -31,900 |
| Cash and cash equivalents and restricted cash at beginning of period | 121,700 | 147,100 | 170,400 | NaN |
| Cash and cash equivalents and restricted cash at end of period | 87,700 | 121,700 | 147,100 | NaN |
Varex Imaging Corp (VREX)
Varex Imaging Corp (VREX)